News | November 28, 2023
Fortis Healthcare to divest Fortis Malar Hospital, Chennai to MGM Healthcare
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Evinova will operate as a separate health-tech business within AstraZeneca
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The company has raised US$4.5 million in funding for its AI operating system
he company posted total income during Q2 FY24 at Rs. 12.86 crore
European operations' revenue grew 58.4% to Rs 599.7 crore
US business grew by +12.8% YoY
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Subscribe To Our Newsletter & Stay Updated
